How to Finance Used Lab Equipment:
What Lenders Actually Look At for LC-MS, HPLC, and ICP-MS.

Used analytical instruments are one of the most misunderstood categories in equipment finance. Most banks won't touch them. Generic brokers don't know how to package them. And lab operators who need financing to acquire a refurbished LC-MS or a dealer-reconditioned HPLC system often get told no before anyone's actually looked at the deal.

The reality is that used lab instruments, particularly high-value analytical systems from major OEMs, are some of the most financeable assets in the secondary equipment market. The problem isn't the equipment. It's that most lenders and brokers don't understand what they're looking at.

Here's what actually determines whether a used lab instrument deal gets financed, and how to position yours correctly.

Why Used Lab Equipment Is Different From Other Asset Classes

When a lender finances a piece of equipment, they're making a collateral-backed bet. If the borrower defaults, the lender repossesses the asset and sells it. Their loss exposure depends on how quickly they can sell it and at what price relative to the outstanding loan balance.

For used lab instruments, that equation is favorable, but only if the lender understands it.

A 2019 Shimadzu LCMS-8060 retained approximately 55-65% of its original purchase price in the secondary market as of recent years. A Waters ACQUITY UPLC system from the same vintage held similar value. These instruments have established dealer networks, active resale markets, and buyers who know exactly what they're acquiring.

That's a stronger collateral position than many categories of "new" equipment with no secondary market to speak of.

The challenge is that most lenders don't have this context. They see "used analytical instrument" and apply a generic haircut to assessed value, or decline outright. The lenders who do understand this market, and they exist, will finance used analytical instruments at competitive rates because they're comfortable with the collateral.

Getting to those lenders, and packaging the deal so it makes sense to them, is the work.

What Lenders Actually Evaluate on Used Lab Instrument Deals

1. Equipment Identity and Pedigree

Lenders want to know exactly what they're financing. Vague descriptions kill deals before they start.

What they need:

• Manufacturer and full model number (not just "Shimadzu mass spec", the specific model matters enormously for residual value)
• Serial number
• Year of manufacture
• Current operational status (running, idle, needs service)
• Software version and license status for systems that require it

The difference between a Shimadzu LCMS-8060NX and an older LCMS-8050 is not trivial. A lender's analyst who knows instruments will spot the difference. A lender who doesn't will lump them together and undervalue both. Our mass spec financing page goes deeper on instrument-specific underwriting.

2. Condition and Service History

This is where most used equipment deals either get approved cleanly or generate additional documentation requests.

Best case: Equipment is covered by an active OEM or third-party service contract, has documented PM (preventive maintenance) records, and is currently in operation. This is the equivalent of a clean Carfax for a used car, it tells the lender the asset has been maintained and is operational.

Acceptable: Equipment has no current service contract but has documented service history and is operational. The lender may require a higher down payment or apply a larger discount to assessed value, but deals still get done.

Harder to finance: Equipment has no service history, unknown operational status, or requires significant repair before use. Not impossible, but the deal structure needs to account for the additional risk, typically through a larger down payment or a stronger borrower credit profile.

For HPLC systems specifically: pump head condition, detector functionality, and whether the autosampler is operational are the key questions a knowledgeable lender will ask. For ICP-MS: torch condition, interface cone status, and quadrupole calibration history matter.

3. Source of the Equipment

Where the equipment is coming from affects how lenders view the deal.

Dealer/reseller: Generally the cleanest scenario for financing. Reputable dealers typically provide inspection reports, verify operational status, and stand behind the equipment. Many can provide financing letters or appraisals that support the purchase price.

Private seller (lab to lab): Financeable but requires more documentation. The lender wants to understand why the selling lab is divesting, downsizing, upgrading, closure. A clear story here prevents underwriting delays.

Auction: More complex. Auction purchases are generally not financed post-purchase, the deal needs to be structured before the hammer drops. Pre-approval for a specific auction lot, or a general pre-approval for a bid ceiling, is the right approach. iLease Capital works specifically with Machinery Resources International auction buyers for this reason.

Estate or bankruptcy sale: Possible but requires careful structuring. The lender will want independent verification of equipment condition and value, typically through a third-party appraisal.

4. The Borrower's Business

Even the strongest collateral doesn't override a borrower that doesn't make sense. For lab financing specifically, lenders want to understand:

What the lab does: A CLIA-certified clinical laboratory with insurance contracts and a Medicare billing number is a different credit profile than a startup research operation. Both can be financed, but differently. The lender wants to see that the equipment purchase is connected to a revenue-generating activity.

Why this instrument: The narrative matters. Acquiring an ICP-MS to expand a cannabis testing menu for existing licensed dispensary clients is a clear revenue story. Acquiring one speculatively to enter a new market is a harder pitch. Being able to articulate the business case for the equipment, not just the desire to own it, moves deals forward.

Time in business and revenue: Labs under two years old can still finance used instruments, but the deal will typically require more documentation: bank statements, any existing client contracts, CLIA certification, and a personal guarantee from the owner. Established labs with two or more years of tax returns have more options and typically better rates.

Packaging a Used Lab Instrument Deal Correctly

The difference between a used lab deal that gets approved quickly and one that stalls in underwriting is almost always documentation and narrative, not the credit profile or the equipment itself.

Here's how to set your deal up properly before submitting:

Assemble these before you apply:

1. Full equipment identification, manufacturer, model, serial number, year, and a brief description of current operational status
2. Any available service records or maintenance documentation
3. Purchase price and source (dealer invoice, auction listing, or private sale agreement)
4. Three months of business bank statements
5. A one-paragraph description of how this instrument fits into your lab's revenue model, what it tests, for whom, at what volume or reimbursement rate

That last item, the narrative, is the one most labs skip. It's also the one that most directly influences whether an underwriter approves a deal or sends back a list of questions.

For deals under $150,000: The above is often sufficient. Many lenders in our network will approve used lab instrument deals at this size on an app-only or simplified basis.

For deals $150,000 to $500,000: Add two years of business tax returns and a current P&L if available. If the equipment is above $200,000, a dealer appraisal or market comparable is helpful.

For deals above $500,000: Full financial package, tax returns, P&L, balance sheet, business debt schedule, and personal financial statements for all guarantors with 20%+ ownership.

The OEM Question: Does Brand Matter?

For secondary market lenders, yes, significantly.

Instruments from established analytical OEMs (Shimadzu, Waters, Agilent, Thermo Fisher, Sciex, PerkinElmer, Beckman Coulter) have documented resale histories and active dealer networks that lenders can reference. When a lender assesses residual value on a Thermo Fisher Orbitrap, there are comparable transactions to reference.

Lesser-known manufacturers, or heavily customized instruments, are harder to value and therefore harder to finance. Not impossible, but the lender's discount to assessed value will typically be larger.

For buyers choosing between two comparable instruments from different manufacturers, the financing implications of that choice are worth factoring in. A slightly more expensive instrument from a major OEM may ultimately cost less to finance than a cheaper one with no secondary market. Browse our HPLC financing page for OEM-specific coverage.

Common Reasons Used Lab Deals Get Declined, and What to Do About Them

"We don't finance used equipment." This is a lender limitation, not a market reality. Move to a lender that specializes in secondary market lab instruments. A broker with 50+ lender relationships can route around this quickly.

"The age of this instrument is a concern." Age matters less than condition and operational status for analytical instruments. A well-maintained 2016 Waters ACQUITY is more financeable than a poorly maintained 2021 one. Lead with condition documentation, not the year.

"We need an appraisal." For higher-value used instruments, this is reasonable. Dealers who specialize in the equipment you're acquiring can typically provide a market value letter quickly, often within 24 to 48 hours. Build this into your timeline.

"We can't verify the equipment value at this price." This happens when a seller is asking above market for an instrument, or when a lender's internal data is outdated. An independent market comparable from a reputable lab equipment dealer will usually resolve this.